Fidget Spinner Rapidly Detects Urinary Tract Infections
|
By LabMedica International staff writers Posted on 16 Jun 2020 |

Image: A fidget spinner for the point-of-care diagnosis of urinary tract infection (Photo courtesy of Ulsan National Institute of Science and Technology).
More than half of all women experience at least one episode of urinary tract infection (UTI) in their lifetime, with men also facing increasing risks of infection as they age. Current detection of UTIs relies on patients reporting symptoms followed by a laboratory culture of the urine for known bacterial culprits, which typically takes a few days.
Doctors tend to prescribe antibiotics to suppress any suspect cases of UTI before they get the test results, contributing to the increasing problem of antibiotic resistance. Dipstick tests that reduce the time taken for diagnoses come with a high chance for false positives. The point-of-care detection of pathogens in biological samples in resource-limited settings should be inexpensive, rapid, portable, simple and accurate.
A multidisciplinary and international team of scientists led by the Ulsan National Institute of Science and Technology (Ulsan, Republic of Korea) developed a fidget spinner-based device to detect UTIs from urine samples. The device was field tested on 39 patients in Tiruchirappalli, India who would have all been given antibiotics based on their symptoms alone. The team reported 59% of the patients were found to be over/under-treated with antibiotics, something that can be rectified using this novel device.
The custom-made fidget spinner rapidly concentrates pathogens in 1-mL samples of undiluted urine by more than 100-fold for the on-device colorimetric detection of bacterial load and pathogen identification. The test of the rectangular device with one or two nudges spins for a long time pushing any bacteria onto a membrane. This is then dyed, with a color change visible to the naked eye in less than one hour, which indicates the amount of bacterial load.
The device enabled the on-site detection of infection with the naked eye within 50 minutes in urine samples from the patients suspected of having a urinary tract infection. The team also showed that, in 30 clinical samples of urinary tract infection, the device can be used to perform an antimicrobial susceptibility test for the antimicrobial drugs ciprofloxacin and cefazolin within 120 minutes.
Another test gave a preliminary indication of the presence of antibiotic resistance. By testing the spun samples treated with different drugs and comparing them to untreated samples, the team was able to quickly make a decision on which antibiotic might work best to treat the UTI. While this does not compare to laboratory based tests for microbial resistance, it is still a useful add-on for resource poor settings that do not typically test for resistance.
The authors concluded that the test can be performed by novices and that there is no extensive training that is required to learn how to spin the device and read the results. The ease-of-use, low price point, availability of quick results, and immediate benefits such as reduction in prescription of antibiotics, makes the new spinner an attractive alternative for diagnosing UTIs. The study was published on May 18, 2020 in the journal Nature Biomedical Engineering.
Related Links:
Ulsan National Institute of Science and Technology
Doctors tend to prescribe antibiotics to suppress any suspect cases of UTI before they get the test results, contributing to the increasing problem of antibiotic resistance. Dipstick tests that reduce the time taken for diagnoses come with a high chance for false positives. The point-of-care detection of pathogens in biological samples in resource-limited settings should be inexpensive, rapid, portable, simple and accurate.
A multidisciplinary and international team of scientists led by the Ulsan National Institute of Science and Technology (Ulsan, Republic of Korea) developed a fidget spinner-based device to detect UTIs from urine samples. The device was field tested on 39 patients in Tiruchirappalli, India who would have all been given antibiotics based on their symptoms alone. The team reported 59% of the patients were found to be over/under-treated with antibiotics, something that can be rectified using this novel device.
The custom-made fidget spinner rapidly concentrates pathogens in 1-mL samples of undiluted urine by more than 100-fold for the on-device colorimetric detection of bacterial load and pathogen identification. The test of the rectangular device with one or two nudges spins for a long time pushing any bacteria onto a membrane. This is then dyed, with a color change visible to the naked eye in less than one hour, which indicates the amount of bacterial load.
The device enabled the on-site detection of infection with the naked eye within 50 minutes in urine samples from the patients suspected of having a urinary tract infection. The team also showed that, in 30 clinical samples of urinary tract infection, the device can be used to perform an antimicrobial susceptibility test for the antimicrobial drugs ciprofloxacin and cefazolin within 120 minutes.
Another test gave a preliminary indication of the presence of antibiotic resistance. By testing the spun samples treated with different drugs and comparing them to untreated samples, the team was able to quickly make a decision on which antibiotic might work best to treat the UTI. While this does not compare to laboratory based tests for microbial resistance, it is still a useful add-on for resource poor settings that do not typically test for resistance.
The authors concluded that the test can be performed by novices and that there is no extensive training that is required to learn how to spin the device and read the results. The ease-of-use, low price point, availability of quick results, and immediate benefits such as reduction in prescription of antibiotics, makes the new spinner an attractive alternative for diagnosing UTIs. The study was published on May 18, 2020 in the journal Nature Biomedical Engineering.
Related Links:
Ulsan National Institute of Science and Technology
Latest Microbiology News
- Precision Screening Helps Close Hepatitis C Diagnosis and Treatment Gaps
- Proteomic Workflow Maps Microbial and Host Responses in Intestinal Inflammation
- Metagenomic Sequencing Enables Faster Diagnosis of Respiratory Infections in Cystic Fibrosis
- Portable Molecular Platform to Advance Point-of-Care Testing for Lassa Fever
- New Sensitive Blood Assay Detects Tuberculosis Antigen Directly in Blood
- Study Highlights Need for Routine Hepatitis E Testing in Cirrhosis
- High-Throughput Automated Platform to Advance Latent Tuberculosis Testing
- Expanded Diagnostics and Therapies Target Rising Gonorrhea Resistance
- New Rapid Ebola Antigen Test Detects Infection at Point of Care
- Syndromic GI Panel Detects Cyclospora for Rapid Case Confirmation
- Rapid Panel Identifies Gram-Negative Pathogens and Resistance Markers in Bloodstream Infections
- Bacterial Growth Assay Predicts COVID-19 Severity From Plasma
- Gut Microbiome Analysis Identifies Frailty-Related Signatures in Older Adults
- CE-Marked Blood Assay Automates Tuberculosis Infection Testing
- Genomic Surveillance Algorithm Improves Early Detection of Emerging Variants
- Rapid Gastrointestinal PCR Panels Deliver One-Hour Results
Channels
Clinical Chemistry
view channel
Portable Troponin Assay Brings Heart Attack Diagnosis Closer to Patients
Timely confirmation of myocardial infarction often depends on laboratory testing that may not be immediately available at the point of care. This gap between clinical suspicion and definitive evidence... Read more
Blood Biomarker Reveals Hidden Disability Progression in Multiple Sclerosis
Multiple sclerosis (MS) remains difficult to monitor because neurological decline can continue even after relapses stop. This progression independent of relapse activity is often subtle and may escape... Read moreMolecular Diagnostics
view channel
New PCR Assays Expand Cyclospora Testing for Outbreak Surveillance
Cyclospora cayetanensis, a food- and waterborne intestinal parasite, can cause prolonged diarrhea, fatigue, and abdominal cramping, placing added strain on urgent care and emergency departments during outbreaks.... Read more
Single Liquid Biopsy Predicts Early Immunotherapy Benefit in Advanced Lung Cancer
Assessing early benefit from immunotherapy in advanced non-small cell lung cancer can be challenging because radiographic responses may take months to become clear. Early scans can also be difficult to... Read moreHematology
view channel
Ultra-Portable Device Enables Finger-Prick Blood Testing at Home
Patients who need frequent blood tests often face repeated clinic visits that burden services and disrupt care. In the UK, millions of tests are performed each year to diagnose disease, guide therapy,... Read more
Age-Specific CBC Reference Intervals Support Pediatric Diagnosis in Vietnam
Complete blood count (CBC) results underpin pediatric evaluation for anemia, infection, inflammation, and platelet disorders. Yet laboratories in Vietnam have largely relied on reference intervals derived... Read moreImmunology
view channel
Study Reveals Immune Mechanism Driving Severe COVID-19 Progression
Severe COVID-19 has highlighted gaps in understanding of early antiviral responses, particularly why some patients deteriorate despite timely care. Type I interferons are central to host defense, yet their... Read more
Antibody Profiling Identifies Preclinical Inflammatory Bowel Disease Years Before Diagnosis
Inflammatory bowel disease often develops after a prolonged symptom-free period, complicating timely recognition and clinical intervention. Limited understanding of immune activity during this silent phase... Read more
Ultrasensitive Blood Test Detects Sjögren’s Signature Years Before Diagnosis
Sjögren’s disease is a common autoimmune condition that can be difficult to recognize early, leading to delayed diagnosis and persistent symptom burden. It affects around half a million people in the UK... Read more
New Assays Expand Cytokine Testing for Transplant and Immunocompromised Patients
Eurofins Viracor has introduced three plasma-based assays—CXCL9 (Test Code 33607), CXCL10 (Test Code 33609), and interleukin-18 (IL-18) (Test Code 33611)—expanding its immunology testing menu for transplant... Read morePathology
view channel
AI Pathology Tool Predicts Relapse Risk in Stage II Colorectal Cancer
Bowel cancer is Australia’s fourth most commonly diagnosed cancer and the second leading cause of cancer death, while remaining the third most common cancer worldwide. In stage-two disease, determining... Read more
AI Pathology Tool Stratifies Rectal Cancer to Guide Chemoradiotherapy
Choosing intensified regimens for locally advanced rectal cancer is challenging because these therapies can cause serious side effects. Colorectal cancer is the fourth-most fatal cancer in the UK, and... Read more
PD-L1 Assay Guides Pembrolizumab Eligibility in Ovarian, Fallopian Tube, and Peritoneal Cancers
Agilent Technologies’ PD-L1 IHC 22C3 pharmDx (Code SK006) has received European Union certification as a companion diagnostic to aid in identifying patients with epithelial ovarian, fallopian tube, or... Read moreTechnology
view channel
Interoperable Data Platform Standardizes Multi-Cancer Blood Test Results
Proteotype Diagnostics has introduced Alchemi, a proprietary data and clinical workflow platform being developed for Enlighten, the company’s investigational blood-based multi-cancer test.... Read more
Training Device Improves Accuracy of Pooled Molecular Diagnostics
High-throughput molecular diagnostics have transformed infectious disease detection, but many workflows remain difficult to execute accurately without extensive training. Sample pooling can cut per‑test... Read more
New CE-Certified Software Advances Whole-Genome Cancer Testing
European hospitals are increasingly using comprehensive tumor genomics to guide therapy, but routine whole genome sequencing (WGS) requires validated, regulation-compliant workflows. A newly CE-certified... Read more
National Rare Disease Registry Standardizes Genetic and Clinical Data for Coordinated Care
Rare diseases collectively impose a significant clinical burden despite their individual rarity, often involving multisystem presentations and prolonged diagnostic journeys. Limited specialist expertise... Read moreIndustry
view channel
Standardized Staining Technology Advances Digital Pathology Workflows
Digital pathology is increasingly used to streamline cancer diagnostics, yet staining variability can hinder slide interpretation and limit the reliability of artificial intelligence tools.... Read more
Global Testing Service Advances Leukemia MRD Monitoring
KMT2A rearrangements drive aggressive subsets of acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) and are associated with relapse and poor outcomes. As menin inhibitors enter clinical... Read more







